StockMacro
Menu

Incannex Healthcare

$1.86 -45% in 6 monthsMarket cap $23.3M

IXHL on XNAS, Health Care, Incannex Healthcare Limited, job postings

Measures activity, not value. Not investment advice.

Shares down 81% in 12 months to $1.86 while the company has $68.3M in cash.

  • BadNet loss of $14.8M over 12 months, free cash flow -$3.2M

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Incannex Healthcare Inc is a clinical-stage biopharmaceutical development company dedicated to developing inventive medicines for patients living with serious chronic diseases and unmet needs. The Company's drug candidates include IHL-42X for the treatment of obstructive sleep apnea (OSA) and PSX-001, the Company's psilocybin treatment in combination with psychological therapy in development to treat patients with generalized anxiety disorder (GAD). The Company also has a drug candidate, IHL-675A, for the treatment of rheumatoid arthritis. Each of these programs target conditions that currently have limited, inadequate, or no approved pharmaceutical treatment options. The Company continues to evaluate strategies for IHL-675A when and as resources permit.

Industry
Pharmaceutical preparations (Health Care)
Employees
12
Website
incannex.com.au
Listed
Nasdaq, US
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $0, net loss $1.9M.
Quarter to 31 Dec 2022: revenue –, net income -$2.9MQuarter to 31 Mar 2023: revenue –, net income -$3.6MQuarter to 30 Jun 2023: revenue –, net income -$4.2MQuarter to 30 Sep 2023: revenue –, net income -$726KQuarter to 31 Dec 2023: revenue –, net income -$5.2MQuarter to 31 Mar 2024: revenue –, net income -$6.0MQuarter to 30 Jun 2024: revenue –, net income -$6.5MQuarter to 30 Sep 2024: revenue $74K, net income -$5.4MQuarter to 30 Sep 2024: revenue $74K, net income -$5.4MQuarter to 31 Dec 2024: revenue $12K, net income -$5.9MQuarter to 31 Dec 2024: revenue $12K, net income -$5.9MQuarter to 31 Mar 2025: revenue –, net income -$4.0MQuarter to 30 Jun 2025: revenue –, net income -$31.6MQuarter to 30 Sep 2025: revenue $0, net income -$6.4MQuarter to 30 Sep 2025: revenue $0, net income -$6.4MQuarter to 31 Dec 2025: revenue –, net income -$6.5MQuarter to 31 Mar 2026: revenue –, net income -$3.9MQuarter to 30 Jun 2026: revenue –, net income -$2.5MQuarter to 30 Sep 2026: revenue $0, net income -$1.9MQuarter to 30 Sep 2026: revenue $0, net income -$1.9M
31 Dec 2022RevenueNet incomeNet losstallest bar $31.6M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$0-$1.9M
30 Jun 2026–-$2.5M
31 Mar 2026–-$3.9M
31 Dec 2025–-$6.5M
30 Sep 2025$0-$6.4M
30 Jun 2025–-$31.6M
31 Mar 2025–-$4.0M
31 Dec 2024$12K-$5.9M
30 Sep 2024$74K-$5.4M
30 Jun 2024–-$6.5M
31 Mar 2024–-$6.0M
31 Dec 2023–-$5.2M
30 Sep 2023–-$726K
30 Jun 2023–-$4.2M
31 Mar 2023–-$3.6M
31 Dec 2022–-$2.9M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. – $12K
Revenue growthRevenue of the last 12 months compared with the 12 months before. – +11%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$14.8M -$47.9M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). -$1.19 -$7.65
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. – – 73.2%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. – – -25.0%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. – – -18.2%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. -20.7% -58.8%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. -$3.2M –
CashCash, cash equivalents and short-term investments on the latest balance sheet. $68.3M $73.3M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $0 –
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). -$68.3M (net cash) –
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 0.0 0.0
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $5.27
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 19.3
P/SPrice to sales: market cap divided by revenue of the last 12 months. – 5.0
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. – 5.0
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 0.35 2.0

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
Incannex HealthcareIXHL (this company) $23.3Mloss–––
ABVC BioPharmaABVC $23.4Mloss–––
Rockwell MedicalRMTI $23.1Mloss0.32-4.0%-7.8%
ScynexisSCYX $23.7Mloss1.3+544%-53.5%
CervoMedCRVO $22.1Mlossover 999-100%–
Briacell TherapeuticsBCTX $26.7Mloss–––

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

–

No data for this company

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

–

No data for this company

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

4.3%

545K shares held by 13F filers (30 Sep 2026) of 12.5M outstanding (9 Nov 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

2.9%

358K shares sold short (30 Oct 2026) of 12.5M outstanding (9 Nov 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

5.7

358K shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-13%

412K shares sold short in the report before, 358K on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

23%

23% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 41%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

–

We do not track this company's careers site yet.

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

We do not track this company's careers site yet.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

–

No data for this company

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

–

No data for this company

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

–

No data for this company

Lobbying What the company reported spending on federal lobbying over the last four quarters.

–

No data for this company

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

6

6 articles in the last 7 days; its usual week has 0 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

–

6 articles in the last 7 days; its usual week has 0: fewer than one, so there is nothing to compare with.

Price $1.86 on 20 Nov 2026, -81% over 12 months (12-month range $1.74 to $14.36)

  • Sharp change
  • 8-K and other filings
Revenue per quarter. Revenue $0 in the latest quarter.
Capital spending per quarter. Capital spending $0 in the latest quarter, -100% on a year earlier.
Institutional holders (13F filers). 16 13F filers reported holding it in the latest 13F quarter, -41% on a year earlier.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: insider net buying (open market), h-1b/e-3 applications certified, federal obligations, lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
17 Mar 20268-K and other filingsDelisting notice or listing transfer
12 Mar 20268-K and other filingsA major agreement ended
2 Dec 2025Sharp changeShort interest spike: short interest spike, 22.3M vs usual 3.6M (2025-11-14); 809.1x the same period a year earlier
18 Nov 2025Sharp changeShort interest spike: short interest spike, 29.3M vs usual 1.7M (2025-10-31); 596.0x the same period a year earlier
28 Oct 2025Sharp changeShort interest spike: short interest spike, 10.2M vs usual 153K (2025-10-15); 145.0x the same period a year earlier
22 Oct 20258-K and other filingsDelisting notice or listing transfer
14 Oct 2025Sharp changeShort interest spike: short interest spike, 5.4M vs usual 103K (2025-09-30); 55.9x the same period a year earlier
30 Sep 2025Sharp changeShort interest spike: short interest spike, 5.5M vs usual 103K (2025-09-15); 45.8x the same period a year earlier
16 Sep 2025Sharp changeShort interest spike: short interest spike, 7.8M vs usual 103K (2025-08-29); 69.1x the same period a year earlier
2 Sep 2025Sharp changeShort interest spike: short interest spike, 4.7M vs usual 93K (2025-08-15); 71.5x the same period a year earlier
12 Aug 2025Sharp changeShort interest spike: short interest spike, 7.2M vs usual 84K (2025-07-31); 185.5x the same period a year earlier
29 Jul 2025Sharp changeShort interest spike: short interest spike, 4.0M vs usual 78K (2025-07-15); 282.9x the same period a year earlier
1 Jul 2025Sharp changeShort interest spike: short interest spike, 4.9M vs usual 71K (2025-06-13); 217.6x the same period a year earlier
17 Jun 2025Sharp changeShort interest spike: short interest spike, 5.2M vs usual 68K (2025-05-30); 153.9x the same period a year earlier
13 Jun 20258-K and other filingsDelisting notice or listing transfer
3 Jun 2025Sharp changeShort interest spike: short interest spike, 8.4M vs usual 64K (2025-05-15); 188.6x the same period a year earlier
28 May 20258-K and other filingsDirector or officer change
28 May 20258-K and other filingsA major agreement ended
28 May 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
13 May 2025Sharp changeShort interest spike: short interest spike, 3.2M vs usual 59K (2025-04-30); 57.5x the same period a year earlier
25 Apr 20258-K and other filingsDelisting notice or listing transfer
16 Apr 20258-K and other filingsRegistered new securities for sale (S-1)
18 Mar 20258-K and other filingsA major agreement ended
14 Mar 20258-K and other filingsPrivate placement of securities (Form D)
10 Jan 20258-K and other filingsDelisting notice or listing transfer
26 Nov 20248-K and other filingsRegistered new securities for sale (S-1)
24 Oct 20248-K and other filingsDirector or officer change
24 Oct 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
17 Jul 20248-K and other filingsRegistered new securities for sale (S-1)
3 Jul 20248-K and other filingsRegistered new securities for sale (S-1)
5 Mar 20248-K and other filingsDirector or officer change
5 Mar 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
15 Dec 20238-K and other filingsChanged its auditor
29 Nov 20238-K and other filingsDirector or officer change
29 Nov 20238-K and other filingsDelisting notice or listing transfer
29 Nov 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
Revenue per quarter
Quarter ended 30 Sep 2024: $74K; public on 15 Nov 2024
Quarter ended 31 Dec 2024: $12K; public on 15 Feb 2025
Quarter ended 30 Sep 2025: $0, -100% on a year earlier; public on 13 Nov 2026
Quarter ended 30 Sep 2026: $0; public on 13 Nov 2026
Capital spending per quarter
Quarter ended 31 Mar 2023: $32K; public on 16 May 2024
Quarter ended 30 Jun 2023: $171K; public on 1 Oct 2024
Quarter ended 30 Sep 2023: $221K; public on 15 Nov 2024
Quarter ended 31 Dec 2023: $59K; public on 15 Feb 2024
Quarter ended 31 Mar 2025: $0; public on 16 May 2025
Quarter ended 30 Jun 2025: $0; public on 30 Sep 2025
Quarter ended 30 Sep 2025: $2K; public on 15 Nov 2025
Quarter ended 31 Dec 2025: $4K; public on 14 Feb 2026
Quarter ended 31 Mar 2026: $5K; public on 16 May 2026
Quarter ended 30 Sep 2026: $0, -100% on a year earlier; public on 13 Nov 2026
Institutional holders (13F filers)
31 Mar 2022 report: 6; public on 16 May 2022
30 Jun 2022 report: 2; public on 15 Aug 2022
30 Sep 2022 report: 4; public on 14 Nov 2022
31 Dec 2022 report: 3; public on 14 Feb 2023
31 Mar 2023 report: 1; public on 15 May 2023
30 Jun 2023 report: 2; public on 14 Aug 2023
30 Sep 2023 report: 4; public on 14 Nov 2023
31 Dec 2023 report: 6; public on 14 Feb 2024
31 Mar 2024 report: 11; public on 15 May 2024
30 Jun 2024 report: 11; public on 14 Aug 2024
30 Sep 2024 report: 10; public on 14 Nov 2024
31 Dec 2024 report: 7; public on 14 Feb 2025
31 Mar 2025 report: 6; public on 15 May 2025
30 Jun 2025 report: 11; public on 14 Aug 2025
30 Sep 2025 report: 27; public on 14 Nov 2025
31 Dec 2025 report: 26; public on 17 Feb 2026
31 Mar 2026 report: 20; public on 15 May 2026
30 Jun 2026 report: 16; public on 14 Aug 2026
30 Sep 2026 report: 16; public on 16 Nov 2026

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is total assets at period end at $70.4M (30 Sep 2026), 3.3× its normal quarter; higher than 69% of its own history.
  • Revenue per quarter: Revenue $0 in the latest quarter.
  • Capital spending per quarter: Capital spending $0 in the latest quarter, -100% on a year earlier.
  • Institutional holders (13F filers): 16 13F filers reported holding it in the latest 13F quarter, -41% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

16 institutions reported shares at the end of Q3 2026, 4% of the shares outstanding; 2 opened a position, 3 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
AdvisorShares Investments LLC168K1.34%$545K+107K+177%
LPL Financial LLC153K1.22%$496K+4,961+3.3%
Millennium Management LLC65K0.51%$209K-31K-32%
Citadel Advisors LLC54K0.43%$174K+43K+418%
HRT Financial LP33K0.27%New+33K
Susquehanna International Group, LLP22K0.18%$71K-6,776-24%
Jane Street Group, LLC16K0.13%$53K-62K-79%
Commonwealth Equity Services, LLC14K0.11%$45KNo change
Morgan Stanley8,1590.07%$26K+4,601+129%
Osaic Holdings, Inc.5,7100.05%$18K-666-10%

Company events

All 28 company events

In 12 months: 1 major agreement, 1 agreement ended, 1 delisting notice. Results releases and routine reports are left out.

FiledWhat happenedSource
17 Mar 2026Delisting notice or listing transfer8-K
12 Mar 2026A major agreement ended8-K
12 Mar 2026Signed a major agreement8-K
22 Oct 2025Delisting notice or listing transfer8-K
13 Jun 2025Delisting notice or listing transfer8-K
28 May 2025Director or officer change; Signed a major agreement; A major agreement endedSame filing: changed its bylaws or fiscal year, shareholder vote results8-K
15 May 2025Signed a major agreement8-K
25 Apr 2025Delisting notice or listing transfer8-K

The 5 newest of 46 articles that name the company.

Timeline
Kind of data

Timeline

Changes and notable records, by the date each became public

  1. 17 Mar 2026Filings record

    Delisting notice or listing transfer

  2. 12 Mar 2026Filings record

    A major agreement ended

  3. 26 Nov 2025Short interest and volume change

    had 22.3M shares sold short in the 14 Nov 2025 report, 809× the same report last year.

    Same report last year: 28K; its normal report is 3.6M.

    See the evidence
    This period
    22.3M (the 14 Nov 2025 report)
    Normal report (median of 24 earlier)
    3.6M
    Typical spread (median absolute deviation)
    3.5M
    How far from its usual level
    +3.6
    Same report last year
    28K
    History used
    1,340 days
    2024-11-15: 28K2024-11-29: 28K2024-12-13: 47K2024-12-31: 62K2025-01-15: 29K2025-01-31: 111K2025-02-14: 89K2025-02-28: 77K2025-03-14: 78K2025-03-31: 72K2025-04-15: 196K2025-04-30: 3.2M2025-05-15: 8.4M2025-05-30: 5.2M2025-06-13: 4.9M2025-06-30: 4.1M2025-07-15: 4.0M2025-07-31: 7.2M2025-08-15: 4.7M2025-08-29: 7.8M2025-09-15: 5.5M2025-09-30: 5.4M2025-10-15: 10.2M2025-10-31: 29.3M2025-11-14: 22.3M
    the 14 Nov 2025 report24 earlier reportsnormal: 3.6M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  4. 13 Nov 2025Short interest and volume change

    had 29.3M shares sold short in the 31 Oct 2025 report, 596× the same report last year.

    Same report last year: 49K; its normal report is 1.7M.

    See the evidence
    This period
    29.3M (the 31 Oct 2025 report)
    Normal report (median of 24 earlier)
    1.7M
    Typical spread (median absolute deviation)
    1.7M
    How far from its usual level
    +11.3
    Same report last year
    49K
    History used
    1,326 days
    2024-10-31: 49K2024-11-15: 28K2024-11-29: 28K2024-12-13: 47K2024-12-31: 62K2025-01-15: 29K2025-01-31: 111K2025-02-14: 89K2025-02-28: 77K2025-03-14: 78K2025-03-31: 72K2025-04-15: 196K2025-04-30: 3.2M2025-05-15: 8.4M2025-05-30: 5.2M2025-06-13: 4.9M2025-06-30: 4.1M2025-07-15: 4.0M2025-07-31: 7.2M2025-08-15: 4.7M2025-08-29: 7.8M2025-09-15: 5.5M2025-09-30: 5.4M2025-10-15: 10.2M2025-10-31: 29.3M
    the 31 Oct 2025 report24 earlier reportsnormal: 1.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  5. 25 Oct 2025Short interest and volume change

    had 10.2M shares sold short in the 15 Oct 2025 report, 145× the same report last year.

    Same report last year: 70K; its normal report is 153K.

    See the evidence
    This period
    10.2M (the 15 Oct 2025 report)
    Normal report (median of 24 earlier)
    153K
    Typical spread (median absolute deviation)
    126K
    How far from its usual level
    +53.8
    Same report last year
    70K
    History used
    1,310 days
    2024-10-15: 70K2024-10-31: 49K2024-11-15: 28K2024-11-29: 28K2024-12-13: 47K2024-12-31: 62K2025-01-15: 29K2025-01-31: 111K2025-02-14: 89K2025-02-28: 77K2025-03-14: 78K2025-03-31: 72K2025-04-15: 196K2025-04-30: 3.2M2025-05-15: 8.4M2025-05-30: 5.2M2025-06-13: 4.9M2025-06-30: 4.1M2025-07-15: 4.0M2025-07-31: 7.2M2025-08-15: 4.7M2025-08-29: 7.8M2025-09-15: 5.5M2025-09-30: 5.4M2025-10-15: 10.2M
    the 15 Oct 2025 report24 earlier reportsnormal: 153K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  6. 22 Oct 2025Filings record

    Delisting notice or listing transfer

  7. 10 Oct 2025Short interest and volume change

    had 5.4M shares sold short in the 30 Sep 2025 report, 56× the same report last year.

    Same report last year: 96K; its normal report is 103K.

    See the evidence
    This period
    5.4M (the 30 Sep 2025 report)
    Normal report (median of 24 earlier)
    103K
    Typical spread (median absolute deviation)
    76K
    How far from its usual level
    +46.9
    Same report last year
    96K
    History used
    1,295 days
    2024-09-30: 96K2024-10-15: 70K2024-10-31: 49K2024-11-15: 28K2024-11-29: 28K2024-12-13: 47K2024-12-31: 62K2025-01-15: 29K2025-01-31: 111K2025-02-14: 89K2025-02-28: 77K2025-03-14: 78K2025-03-31: 72K2025-04-15: 196K2025-04-30: 3.2M2025-05-15: 8.4M2025-05-30: 5.2M2025-06-13: 4.9M2025-06-30: 4.1M2025-07-15: 4.0M2025-07-31: 7.2M2025-08-15: 4.7M2025-08-29: 7.8M2025-09-15: 5.5M2025-09-30: 5.4M
    the 30 Sep 2025 report24 earlier reportsnormal: 103K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  8. 25 Sep 2025Short interest and volume change

    had 5.5M shares sold short in the 15 Sep 2025 report, 46× the same report last year.

    Same report last year: 121K; its normal report is 103K.

    See the evidence
    This period
    5.5M (the 15 Sep 2025 report)
    Normal report (median of 24 earlier)
    103K
    Typical spread (median absolute deviation)
    75K
    How far from its usual level
    +48.8
    Same report last year
    121K
    History used
    1,280 days
    2024-09-13: 121K2024-09-30: 96K2024-10-15: 70K2024-10-31: 49K2024-11-15: 28K2024-11-29: 28K2024-12-13: 47K2024-12-31: 62K2025-01-15: 29K2025-01-31: 111K2025-02-14: 89K2025-02-28: 77K2025-03-14: 78K2025-03-31: 72K2025-04-15: 196K2025-04-30: 3.2M2025-05-15: 8.4M2025-05-30: 5.2M2025-06-13: 4.9M2025-06-30: 4.1M2025-07-15: 4.0M2025-07-31: 7.2M2025-08-15: 4.7M2025-08-29: 7.8M2025-09-15: 5.5M
    the 15 Sep 2025 report24 earlier reportsnormal: 103K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  9. 11 Sep 2025Short interest and volume change

    had 7.8M shares sold short in the 29 Aug 2025 report, 69× the same report last year.

    Same report last year: 113K; its normal report is 103K.

    See the evidence
    This period
    7.8M (the 29 Aug 2025 report)
    Normal report (median of 24 earlier)
    103K
    Typical spread (median absolute deviation)
    65K
    How far from its usual level
    +79.7
    Same report last year
    113K
    History used
    1,263 days
    2024-08-30: 113K2024-09-13: 121K2024-09-30: 96K2024-10-15: 70K2024-10-31: 49K2024-11-15: 28K2024-11-29: 28K2024-12-13: 47K2024-12-31: 62K2025-01-15: 29K2025-01-31: 111K2025-02-14: 89K2025-02-28: 77K2025-03-14: 78K2025-03-31: 72K2025-04-15: 196K2025-04-30: 3.2M2025-05-15: 8.4M2025-05-30: 5.2M2025-06-13: 4.9M2025-06-30: 4.1M2025-07-15: 4.0M2025-07-31: 7.2M2025-08-15: 4.7M2025-08-29: 7.8M
    the 29 Aug 2025 report24 earlier reportsnormal: 103K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  10. 27 Aug 2025Short interest and volume change

    had 4.7M shares sold short in the 15 Aug 2025 report, 72× the same report last year.

    Same report last year: 66K; its normal report is 93K.

    See the evidence
    This period
    4.7M (the 15 Aug 2025 report)
    Normal report (median of 24 earlier)
    93K
    Typical spread (median absolute deviation)
    45K
    How far from its usual level
    +69.2
    Same report last year
    66K
    History used
    1,249 days
    2024-08-15: 66K2024-08-30: 113K2024-09-13: 121K2024-09-30: 96K2024-10-15: 70K2024-10-31: 49K2024-11-15: 28K2024-11-29: 28K2024-12-13: 47K2024-12-31: 62K2025-01-15: 29K2025-01-31: 111K2025-02-14: 89K2025-02-28: 77K2025-03-14: 78K2025-03-31: 72K2025-04-15: 196K2025-04-30: 3.2M2025-05-15: 8.4M2025-05-30: 5.2M2025-06-13: 4.9M2025-06-30: 4.1M2025-07-15: 4.0M2025-07-31: 7.2M2025-08-15: 4.7M
    the 15 Aug 2025 report24 earlier reportsnormal: 93K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  11. 12 Aug 2025Short interest and volume change

    had 7.2M shares sold short in the 31 Jul 2025 report, 185× the same report last year.

    Same report last year: 39K; its normal report is 84K.

    See the evidence
    This period
    7.2M (the 31 Jul 2025 report)
    Normal report (median of 24 earlier)
    84K
    Typical spread (median absolute deviation)
    37K
    How far from its usual level
    +129.8
    Same report last year
    39K
    History used
    1,234 days
    2024-07-31: 39K2024-08-15: 66K2024-08-30: 113K2024-09-13: 121K2024-09-30: 96K2024-10-15: 70K2024-10-31: 49K2024-11-15: 28K2024-11-29: 28K2024-12-13: 47K2024-12-31: 62K2025-01-15: 29K2025-01-31: 111K2025-02-14: 89K2025-02-28: 77K2025-03-14: 78K2025-03-31: 72K2025-04-15: 196K2025-04-30: 3.2M2025-05-15: 8.4M2025-05-30: 5.2M2025-06-13: 4.9M2025-06-30: 4.1M2025-07-15: 4.0M2025-07-31: 7.2M
    the 31 Jul 2025 report24 earlier reportsnormal: 84K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  12. 25 Jul 2025Short interest and volume change

    had 4.0M shares sold short in the 15 Jul 2025 report, 283× the same report last year.

    Same report last year: 14K; its normal report is 78K.

    See the evidence
    This period
    4.0M (the 15 Jul 2025 report)
    Normal report (median of 24 earlier)
    78K
    Typical spread (median absolute deviation)
    37K
    How far from its usual level
    +70.1
    Same report last year
    14K
    History used
    1,218 days
    2024-07-15: 14K2024-07-31: 39K2024-08-15: 66K2024-08-30: 113K2024-09-13: 121K2024-09-30: 96K2024-10-15: 70K2024-10-31: 49K2024-11-15: 28K2024-11-29: 28K2024-12-13: 47K2024-12-31: 62K2025-01-15: 29K2025-01-31: 111K2025-02-14: 89K2025-02-28: 77K2025-03-14: 78K2025-03-31: 72K2025-04-15: 196K2025-04-30: 3.2M2025-05-15: 8.4M2025-05-30: 5.2M2025-06-13: 4.9M2025-06-30: 4.1M2025-07-15: 4.0M
    the 15 Jul 2025 report24 earlier reportsnormal: 78K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  13. 26 Jun 2025Short interest and volume change

    had 4.9M shares sold short in the 13 Jun 2025 report, 218× the same report last year.

    Same report last year: 23K; its normal report is 71K.

    See the evidence
    This period
    4.9M (the 13 Jun 2025 report)
    Normal report (median of 24 earlier)
    71K
    Typical spread (median absolute deviation)
    41K
    How far from its usual level
    +80.5
    Same report last year
    23K
    History used
    1,186 days
    2024-06-14: 23K2024-06-28: 7,0352024-07-15: 14K2024-07-31: 39K2024-08-15: 66K2024-08-30: 113K2024-09-13: 121K2024-09-30: 96K2024-10-15: 70K2024-10-31: 49K2024-11-15: 28K2024-11-29: 28K2024-12-13: 47K2024-12-31: 62K2025-01-15: 29K2025-01-31: 111K2025-02-14: 89K2025-02-28: 77K2025-03-14: 78K2025-03-31: 72K2025-04-15: 196K2025-04-30: 3.2M2025-05-15: 8.4M2025-05-30: 5.2M2025-06-13: 4.9M
    the 13 Jun 2025 report24 earlier reportsnormal: 71K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  14. 13 Jun 2025Filings record

    Delisting notice or listing transfer

  15. 11 Jun 2025Short interest and volume change

    had 5.2M shares sold short in the 30 May 2025 report, 154× the same report last year.

    Same report last year: 34K; its normal report is 68K.

    See the evidence
    This period
    5.2M (the 30 May 2025 report)
    Normal report (median of 24 earlier)
    68K
    Typical spread (median absolute deviation)
    36K
    How far from its usual level
    +94.6
    Same report last year
    34K
    History used
    1,172 days
    2024-05-31: 34K2024-06-14: 23K2024-06-28: 7,0352024-07-15: 14K2024-07-31: 39K2024-08-15: 66K2024-08-30: 113K2024-09-13: 121K2024-09-30: 96K2024-10-15: 70K2024-10-31: 49K2024-11-15: 28K2024-11-29: 28K2024-12-13: 47K2024-12-31: 62K2025-01-15: 29K2025-01-31: 111K2025-02-14: 89K2025-02-28: 77K2025-03-14: 78K2025-03-31: 72K2025-04-15: 196K2025-04-30: 3.2M2025-05-15: 8.4M2025-05-30: 5.2M
    the 30 May 2025 report24 earlier reportsnormal: 68K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  16. 28 May 2025Short interest and volume change

    had 8.4M shares sold short in the 15 May 2025 report, 189× the same report last year.

    Same report last year: 45K; its normal report is 64K.

    See the evidence
    This period
    8.4M (the 15 May 2025 report)
    Normal report (median of 24 earlier)
    64K
    Typical spread (median absolute deviation)
    31K
    How far from its usual level
    +167.2
    Same report last year
    45K
    History used
    1,157 days
    2024-05-15: 45K2024-05-31: 34K2024-06-14: 23K2024-06-28: 7,0352024-07-15: 14K2024-07-31: 39K2024-08-15: 66K2024-08-30: 113K2024-09-13: 121K2024-09-30: 96K2024-10-15: 70K2024-10-31: 49K2024-11-15: 28K2024-11-29: 28K2024-12-13: 47K2024-12-31: 62K2025-01-15: 29K2025-01-31: 111K2025-02-14: 89K2025-02-28: 77K2025-03-14: 78K2025-03-31: 72K2025-04-15: 196K2025-04-30: 3.2M2025-05-15: 8.4M
    the 15 May 2025 report24 earlier reportsnormal: 64K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  17. 28 May 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  18. 28 May 2025Filings record

    Director or officer change

  19. 28 May 2025Filings record

    A major agreement ended

  20. 10 May 2025Short interest and volume change

    had 3.2M shares sold short in the 30 Apr 2025 report, 58× the same report last year.

    Same report last year: 55K; its normal report is 59K.

    See the evidence
    This period
    3.2M (the 30 Apr 2025 report)
    Normal report (median of 24 earlier)
    59K
    Typical spread (median absolute deviation)
    27K
    How far from its usual level
    +62.0
    Same report last year
    55K
    History used
    1,142 days
    2024-04-30: 55K2024-05-15: 45K2024-05-31: 34K2024-06-14: 23K2024-06-28: 7,0352024-07-15: 14K2024-07-31: 39K2024-08-15: 66K2024-08-30: 113K2024-09-13: 121K2024-09-30: 96K2024-10-15: 70K2024-10-31: 49K2024-11-15: 28K2024-11-29: 28K2024-12-13: 47K2024-12-31: 62K2025-01-15: 29K2025-01-31: 111K2025-02-14: 89K2025-02-28: 77K2025-03-14: 78K2025-03-31: 72K2025-04-15: 196K2025-04-30: 3.2M
    the 30 Apr 2025 report24 earlier reportsnormal: 59K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  21. 25 Apr 2025Filings record

    Delisting notice or listing transfer

  22. 16 Apr 2025Filings record

    Registered new securities for sale (S-1)

  23. 18 Mar 2025Filings record

    A major agreement ended

  24. 14 Mar 2025Filings record

    Private placement of securities (Form D)

  25. 10 Jan 2025Filings record

    Delisting notice or listing transfer

  26. 26 Nov 2024Filings record

    Registered new securities for sale (S-1)

  27. 24 Oct 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  28. 24 Oct 2024Filings record

    Director or officer change

  29. 17 Jul 2024Filings record

    Registered new securities for sale (S-1)

  30. 3 Jul 2024Filings record

    Registered new securities for sale (S-1)

  31. 5 Mar 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  32. 5 Mar 2024Filings record

    Director or officer change

  33. 15 Dec 2023Filings record

    Changed its auditor

  34. 29 Nov 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  35. 29 Nov 2023Filings record

    Director or officer change

  36. 29 Nov 2023Filings record

    Delisting notice or listing transfer

Not listed: 76 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001873875
Ticker
IXHL
Domain
incannex.com.au
Name
Incannex Healthcare Limited
  • SEC Form 13F institutional holdings171 data points31 Mar 2022 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)95 records28 Oct 2022 to 12 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)213 data points30 Jun 2020 to 9 Nov 2026
  • FINRA short interest (twice monthly)335 data points15 Mar 2022 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)2356 data points25 Feb 2022 to 20 Nov 2026